Skip to content

Clinical trials

Myeloproliferative Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: United Kingdom Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20052
20071
20092
20122
20135
20142
20151
20171
20182
20195
20203
20217
20223
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting11
Terminated6
Recruiting4
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation8
Novartis Pharmaceuticals5
Celgene3
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
AbbVie2
CTI BioPharma2
Italfarmaco2
Ariad Pharmaceuticals1
Cogent Biosciences, Inc.1
Constellation Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders44
Primary Myelofibrosis23
Thrombocythemia, Essential15
Leukemia11
Polycythemia Vera11
Bone Marrow Diseases9
Hematologic Diseases9
Myelodysplastic Syndromes9
Leukemia, Myeloid, Acute8
Leukemia, Myelomonocytic, Chronic6

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.